Key result
Angiotensin II impairs neurovascular coupling via AT1R and NADPH oxidase-dependent ROS production independently of blood pressure, highlighting a potential therapeutic target for Alzheimer's disease.
Why the study?
How does Angiotensin II affect neurovascular coupling in the context of neurodegenerative diseases?
How does Angiotensin II affect neurovascular coupling in the context of neurodegenerative diseases?
Angiotensin II impairs neurovascular coupling via ROS production independently of blood pressure, suggesting a potential therapeutic target for neurodegenerative diseases like Alzheimer's.
Answers are grounded in this paper and cite their sources.
AT1R blockade unproven for neurovascular protection in Alzheimer's; leaves open hypothesis-generating target requiring clinical trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bloch et al. (2015) conducted a review in Neurodegenerative diseases, Alzheimer's disease. Angiotensin II was evaluated. Angiotensin II impairs neurovascular coupling via AT1R and NADPH oxidase-dependent ROS production independently of blood pressure, highlighting a potential therapeutic target for Alzheimer's disease.
Synapse has enriched 10 related papers. Consider them for comparative context: